It all began in July 2018. I was called upon to contribute to the birth of a new, ambitious project—the creation of not just another journal but an entirely new brand that could offer a unified platform for the many clinical disciplines spanning medical and surgical fields. In an era of cross-disciplinary approaches and clinical interconnections, the project appeared both ambitious and bold. Entering a crowded space, filled with high-impact journals as well as many short-lived ones, risked confusing readers and authors, making the effort seem like a hazardous experiment. Yet, I accepted this major challenge with great enthusiasm, aware that a phase of steady growth would only follow a cautious and selective beginning.
Then came COVID-19, and with it, an overwhelming surge in publications—a flood that also reached SN Comprehensive Clinical Medicine. Like all journals, the sheer volume of scientific output during that period did not always match its quality, leaving us, like many others, facing a reset in 2021. With new benchmarks and hard-earned experience, the second phase of growth began, driven by a decisive kinetic phenomenon (Newton’s Second Law), as citations and journal usage started rising at a steady pace.
Observing this trend and awaiting further consolidation—based on the global origin of manuscripts and a 28% acceptance rate—we launched thematic series with cross-disciplinary and cross-cultural relevance, anchored in SDG3 and SDG5.
The time had finally come to pursue inclusion in major indexing services, starting with Scopus.
Now that we have secured Scopus indexing and are swiftly moving toward inclusion in other leading databases, we can confidently hope for a prominent role for our journal.
A long spring has allowed for the proper transformation of flower into fruit, and we trust that this long-awaited fruit set will nourish and serve the global medical community.
Paolo Martelletti, Editor-in-Chief